Literature DB >> 27369358

Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease.

Diane Armao1,2, Rachel M Bailey3, Thomas W Bouldin1, Yongbaek Kim4, Steven J Gray5,6.   

Abstract

PURPOSE: Giant axonal neuropathy (GAN) is an inherited severe sensorimotor neuropathy. The aim of this research was to investigate the neuropathologic features and clinical autonomic nervous system (ANS) phenotype in two GAN knockout (KO) mouse models. Little is known about ANS involvement in GAN in humans, but autonomic signs and symptoms are commonly reported in early childhood.
METHODS: Routine histology and immunohistochemistry was performed on GAN KO mouse specimens taken at various ages. Enteric dysfunction was assessed by quantifying the frequency, weight, and water content of defecation in GAN KO mice.
RESULTS: Histological examination of the enteric, parasympathetic and sympathetic ANS of GAN KO mice revealed pronounced and widespread neuronal perikaryal intermediate filament inclusions. These neuronal inclusions served as an easily identifiable, early marker of GAN in young GAN KO mice. Functional studies identified an age-dependent alteration in fecal weight and defecation frequency in GAN KO mice.
CONCLUSIONS: For the first time in the GAN KO mouse model, we described the early, pronounced and widespread neuropathologic features involving the ANS. In addition, we provided evidence for a clinical autonomic phenotype in GAN KO mice, reflected in abnormal gastrointestinal function. These findings in GAN KO mice suggest that consideration should be given to ANS involvement in human GAN, especially when considering treatments and patient care.

Entities:  

Keywords:  Autonomic nervous system; Giant axonal neuropathy; Gigaxonin; Intermediate filaments; Neurodegenerative disease

Mesh:

Year:  2016        PMID: 27369358      PMCID: PMC5057391          DOI: 10.1007/s10286-016-0365-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  14 in total

1.  Measuring disease progression in giant axonal neuropathy: implications for clinical trial design.

Authors:  Lisa A Roth; Jonathan D Marra; Nicole H LaMarca; Douglas M Sproule
Journal:  J Child Neurol       Date:  2014-09-03       Impact factor: 1.987

2.  Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy.

Authors:  S D Pena; M Opas; K Turksen; V I Kalnins; S Carpenter
Journal:  Eur J Cell Biol       Date:  1983-09       Impact factor: 4.492

3.  Giant axonal neuropathy: clinical and genetic study in six cases.

Authors:  E Demir; P Bomont; S Erdem; L Cavalier; M Demirci; G Kose; S Muftuoglu; A N Cakar; E Tan; S Aysun; M Topcu; P Guicheney; M Koenig; H Topaloglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

4.  Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathy.

Authors:  Silke Mussche; Bart Devreese; Sahana Nagabhushan Kalburgi; Lavanya Bachaboina; Jonathan C Fox; Hung-Jui Shih; Rudy Van Coster; R Jude Samulski; Steven J Gray
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

5.  Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein.

Authors:  Lixin Wang; Sheila M Fleming; Marie-Françoise Chesselet; Yvette Taché
Journal:  Neuroreport       Date:  2008-05-28       Impact factor: 1.837

6.  Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease.

Authors:  Grant Anderson; Ali Reza Noorian; Georgia Taylor; Mallappa Anitha; Doug Bernhard; Shanthi Srinivasan; James G Greene
Journal:  Exp Neurol       Date:  2007-05-18       Impact factor: 5.330

7.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

8.  Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.

Authors:  Tonya N Taylor; W Michael Caudle; Kennie R Shepherd; AliReza Noorian; Chad R Jackson; P Michael Iuvone; David Weinshenker; James G Greene; Gary W Miller
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

9.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

10.  Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy.

Authors:  Lori Sames; Allison Moore; Renee Arnold; Sean Ekins
Journal:  F1000Res       Date:  2014-04-03
View more
  4 in total

Review 1.  Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.

Authors:  Rachel M Bailey; Alejandra Rozenberg; Steven J Gray
Journal:  Brain Res       Date:  2020-04-11       Impact factor: 3.252

2.  Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment

Authors:  Po-Han Chen; Jimin Hu; Jianli Wu; Duc T Huynh; Timothy J Smith; Samuel Pan; Brittany J Bisnett; Alexander B Smith; Annie Lu; Brett M Condon; Jen-Tsan Chi; Michael Boyce
Journal:  JCI Insight       Date:  2019-11-26

3.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

4.  Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens.

Authors:  Diane Armao; Thomas W Bouldin; Rachel M Bailey; Jody E Hooper; Diana X Bharucha; Steven J Gray
Journal:  Orphanet J Rare Dis       Date:  2019-02-01       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.